Search Results

• • 1,849 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Bulletin Board

  From:Future Virology (Vol. 9, Issue 7)

  July 2014276 words Brief article 1570LNovel diagnostic approach may help identify the millions of individuals who are unknowingly infected. Each year, between 350,000 and 500,000 individuals die from hepatitis C (HCV)-related liver diseases, and while...

• Chronic HCV patients have higher all-cause mortality

  From:Clinical Advisor (Vol. 14, Issue 7)

  July 201129 words Brief article 1650LPatients with chronic hepatitis C infection had a greater than twofold risk of dying from both liver and non-liver-related causes compared with those who tested negative for the disease....

• The safety of anti-TNF therapy in patients with hepatitis B and C virus infection

  Authors:Dimitrios Vassilopoulos and George V PapatheodoridisFrom:International Journal of Clinical Rheumatology (Vol. 7, Issue 2) Peer-Reviewed

  Apr. 20123,704 words Article 1620LAuthor(s): Dimitrios Vassilopoulos [**] 2 , George V Papatheodoridis 1 KEYWORDS : anti-TNF agents; hepatitis B virus; hepatitis C virus; inflammatory bowel diseases; rheumatoid arthritis; spondyloarthropathies...

• Chronic hepatitis C infection and insulin resistance: two best friends

  Authors:Ludovico Abenavoli and Piero L. AlmasioFrom:Expert Review of Anti-infective Therapy (Vol. 9, Issue 8) Peer-Reviewed

  Aug. 20112,443 words Report 1300LAuthor(s): Ludovico Abenavoli [[dagger]] 1 , Piero L Almasio 2 Keywords : HCV; insulin resistance; interferon resistance; liver steatosis Approximately 170 million people worldwide are chronically infected...

• Limited evidence of HCV transmission in stable heterosexual couples from Bahia, Brazil

  Authors:Marcia Bessa, Itatiana Ferreira Rodart, Gisele Barreto Lopes Menezes, Theomira Mauadi de Azevedo Carmo, Daniel A. Athanazio, and Mitermayer G. ReisFrom:The Brazilian Journal of Infectious Diseases (Vol. 13, Issue 4) Peer-Reviewed

  July-August 20093,168 words Article 1360LHCV infected patients frequently ask their physician about the risk of transmission to their partners. Although it is easy to answer that the risk does exist, it is difficult to quantify. We studied the transmission of...

• Effect of Antiviral Therapy on Hepatitis C Virus Related Glomerulopathy

  Authors:Ghulam Abbas, Shahid Hussain, and Tahir ShafiFrom:Saudi Journal of Kidney Diseases and Transplantation (Vol. 19, Issue 5) Peer-Reviewed

  September-October 20082,646 words Article 1530LByline: Ghulam. Abbas, Shahid. Hussain, Tahir. Shafi To determine the efficacy of antiviral therapy in hepatitis C virus associated glome-rulopathy, we studied 30 patients with HCV-associated glomerulopathy at Sheikh...

• Neonatal and Pediatric Posttransfusion Hepatitis C: A Look Back and a Look Forward

  Authors:Richard D. Aach, Roslyn A. Yomtovian, and Maureen HackFrom:Pediatrics (Vol. 105, Issue 4) Peer-Reviewed

  Apr. 20006,357 words Article ABBREVIATIONS. HCV, hepatitis C virus; NANB, non-A, non-B hepatitis; RIBA, recombinant immunoblot assay; HIV, human immunodeficiency virus; ALT, alanine aminotransferase; FDA, Food and Drug Administration. Ten years...

• Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase

  Authors:Sergey A. Shiryaev, Anton V. Cheltsov, and Alex Y. StronginFrom:PLoS ONE (Vol. 7, Issue 7) Peer-Reviewed

  July 2, 20128,320 words Article 1440LAuthor(s): Sergey A. Shiryaev 1 , Anton V. Cheltsov 2 , * , Alex Y. Strongin 1 , * Introduction Hepatitis C is a treatment-resistant disease with over 200 million people infected worldwide. Over 80% of infected...

• Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver

  Authors:Satoshi Sekiguchi, Kiminori Kimura, Tomoko Chiyo, Takahiro Ohtsuki, Yoshimi Tobita, Yuko Tokunaga, et al.From:PLoS ONE (Vol. 7, Issue 12) Peer-Reviewed

  Dec. 17, 20127,355 words Article 1420LAuthor(s): Satoshi Sekiguchi 1 , Kiminori Kimura 2 , Tomoko Chiyo 1 , Takahiro Ohtsuki 1 , Yoshimi Tobita 1 , Yuko Tokunaga 1 , Fumihiko Yasui 1 , Kyoko Tsukiyama-Kohara 3 , Takaji Wakita 4 , Toshiyuki Tanaka 5 ,...

• Sequence Heterogeneity in NS5A of Hepatitis C Virus Genotypes 2a and 2b and Clinical Outcome of Pegylated-Interferon/Ribavirin Therapy

  Authors:Ahmed El-Shamy, Ikuo Shoji, Soo-Ryang Kim, Yoshihiro Ide, Susumu Imoto, Lin Deng, et al.From:PLoS ONE (Vol. 7, Issue 2) Peer-Reviewed

  Feb. 2, 20126,290 words Article 1530LAuthor(s): Ahmed El-Shamy 1 , 2 , Ikuo Shoji 1 , Soo-Ryang Kim 3 , Yoshihiro Ide 1 , Susumu Imoto 3 , Lin Deng 1 , Seitetsu Yoon 4 , Takashi Fujisawa 5 , Satoshi Tani 6 , Yoshihiko Yano 7 , Yasushi Seo 7 , Takeshi Azuma...

• Identification of Hidden Key Hepatitis C Populations: An Evaluation of Screening Practices Using Mixed Epidemiological Methods

  Authors:Angelique P. A. Vermeiren, Nicole H. T. M. Dukers-Muijrers, Inge H. M. van Loo, Frans Stals, Dirk W. van Dam, Ton Ambergen, et al.From:PLoS ONE (Vol. 7, Issue 12) Peer-Reviewed

  Dec. 7, 20124,918 words Article 1480LAuthor(s): Angelique P. A. Vermeiren 1 , * , Nicole H. T. M. Dukers-Muijrers 1 , 2 , Inge H. M. van Loo 2 , Frans Stals 3 , Dirk W. van Dam 4 , Ton Ambergen 5 , Christian J. P. A. Hoebe 1 , 2 Introduction...

• A Novel Method to Identify Routes of Hepatitis C Virus Transmission

  Authors:Cyrille Feray, Julie Bouscaillou, Bruno Falissard, Mostafa K. Mohamed, Naglaa Arafa, Iman Bakr, et al.From:PLoS ONE (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 23, 20144,323 words Disease/Disorder ove... 1560LAuthor(s): Cyrille Féray 1,*, Julie Bouscaillou 2, Bruno Falissard 3, Mostafa K. Mohamed 4, Naglaa Arafa 4, Iman Bakr 4, Mostafa El-Hoseiny 4, Mai El Daly 5,6, Sherif El-Kafrawy 5,6, Sabine Plancoulaine 7, Mohamed...

• CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users

  Authors:Kristi Huik, Radko Avi, Andrew Carrillo, Nathan Harper, Merit Pauskar, Maarja Sadam, et al.From:PLoS ONE (Vol. 8, Issue 7) Peer-Reviewed

  July 25, 20135,995 words Article 1520LAuthor(s): Kristi Huik 1, Radko Avi 1, Andrew Carrillo 2,3, Nathan Harper 2,3, Merit Pauskar 1, Maarja Sadam 1, Tõnis Karki 1, Tõnu Krispin 1, Ulvi-Kaire Kongo 4, Tatiana Jermilova 5, Kristi Rüütel 6, Ave Talu 6, Katri...

• Kinetics of miR-122 Expression in the Liver during Acute HCV Infection

  Authors:Youkyung Choi, Hans-Peter Dienes, and Kris KrawczynskiFrom:PLoS ONE (Vol. 8, Issue 10) Peer-Reviewed

  Oct. 4, 20134,876 words Article 1570LAuthor(s): Youkyung Choi 1, Hans-Peter Dienes 2, Kris Krawczynski 1,* Introduction More than 170 million people world-wide are estimated to be chronically infected with HCV, and in the USA, about 25,000...

• Concurrent infection with hepatitis C Virus and Streptococcus pneumoniae

  Authors:Thomas J. Marrie, Gregory J. Tyrrell, Sumit R. Majumdar, and Dean T. EurichFrom:Emerging Infectious Diseases (Vol. 23, Issue 7) Peer-Reviewed

  July 20173,950 words Article 1430LLittle is known about concurrent infection with hepatitis C virus (HCV) and Streptococcus pneumoniae, which causes invasive pneumococcal disease (IPD). We hypothesized that co-infection with HCV and S. pneumoniae would...

• Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation

  Authors:Daisuke Yamane, David R. McGivern, Eliane Wauthier, MinKyung Yi, Victoria J. Madden, Christoph Welsch, et al.From:Nature Medicine (Vol. 20, Issue 8) Peer-Reviewed

  Aug. 20148,852 words Report 1490LOxidative tissue injury often accompanies viral infection, yet there is little understanding of how it influences virus replication. We show that multiple hepatitis C virus (HCV) genotypes are exquisitely sensitive to...

• Binding of Hepatitis C Virus to CD81

  Authors:Piero Pileri, Yasushi Uematsu, Susanna Campagnoli, Giuliano Galli, Fabiana Falugi, Roberto Petracca, et al.From:Science (Vol. 282, Issue 5390) Peer-Reviewed

  Oct. 30, 19982,905 words Article Chronic hepatitis C virus (HCV) infection occurs in about 3 percent of the world's population and is a major cause of liver disease. HCV infection is also associated with cryoglobulinemia, a B lymphocyte proliferative...

• Bone density risk factors in people with HIV: a long, familiar list

  Author:Mark MascoliniFrom:Research Initiative/Treatment Action! (Vol. 20, Issue 2) Peer-Reviewed

  Fall 20154,006 words Article 1680LA list of osteoporosis risk factors compiled by the National Osteoporosis Foundation is long and detailed, yet it omits two factors confirmed by research and highly prevalent in people with HIV: HCV or HBV infection and...

• Breakthrough therapy for HCV infection

  From:Clinical Advisor (Vol. 17, Issue 3)

  Mar. 2014613 words Drug overview 1300LProduct: Sovaldi Company: Gilead Sciences Pharmacologic class: Hepatitis C virus (HCV) NS5B polymerase inhibitor. Active ingredient: Sofosbuvir 400mg; tabs. Indication: As a component of a combination...

• Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis

  Authors:Eduardo Vilar Gomez, Ana Torres Gonzalez, Luis Calzadilla Bertot, Ali Yasells Garcia, Yoan Sanchez Rodriguez, and Yadina Martinez PerezFrom:PLoS ONE (Vol. 9, Issue 4) Peer-Reviewed

  Apr. 20145,306 words Report 1480LBackground: Arterial blood pressure (BP) is a reliable marker of circulatory dysfunction in cirrhotic patients. There are no prospective studies evaluating the association between different levels of arterial BP and...